AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

Moody, Terry W; Tashakkori, Nicole; Mantey, Samuel A; Moreno, Paola; Ramos-Alvarez, Irene; Leopoldo, Marcello; Jensen, Robert T

Moody, Terry W; Tashakkori, Nicole; Mantey, Samuel A; Moreno, Paola; Ramos-Alvarez, Irene; Leopoldo, Marcello; Jensen, Robert T.

Afiliación

Moody TW; Department of Health and Human Services, National Cancer Institute, Center for Cancer Research, Bethesda, MD, United States.
Tashakkori N; Department of Health and Human Services, National Cancer Institute, Center for Cancer Research, Bethesda, MD, United States.
Mantey SA; National Institute of Diabetes, Digestive and Kidney Disease, Digestive Diseases Branch, Bethesda, MD, United States.
Moreno P; National Institute of Diabetes, Digestive and Kidney Disease, Digestive Diseases Branch, Bethesda, MD, United States.
Ramos-Alvarez I; National Institute of Diabetes, Digestive and Kidney Disease, Digestive Diseases Branch, Bethesda, MD, United States.
Leopoldo M; Dipartimento di Farmacia, Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Bari, Italy.
Jensen RT; National Institute of Diabetes, Digestive and Kidney Disease, Digestive Diseases Branch, Bethesda, MD, United States.

Front Endocrinol (Lausanne) ; 8: 176, 2017.

Article en En | MEDLINE | ID: mdl-28785244

Palabras clave

GRPR; NMBR; bombesin receptor subtype-3; lung cancer; small molecule antagonists

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google